http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101036854-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1761 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4747 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 |
| filingDate | 2008-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101036854-B1 |
| titleOfInvention | Polypeptide inducing apoptosis, DNA encoding the same and a pharmaceutical composition for inducing apoptosis comprising the same |
| abstract | The present invention induces apoptosis despite not binding to myeloid cell leukemia-1 long (Mcl-1L), an anti-apoptotic protein, which is different from pro-apoptotic Bcl-2 family proteins. A polypeptide, DNA encoding the same and a pharmaceutical composition for inducing apoptosis comprising the same, the pharmaceutical composition of the present invention can be usefully used for the treatment of various cancers, including hematological cancer and solid cancer.n n n n Apoptosis, Mcl-1L, Mcl-1ES BH3M, Anticancer Drug |
| priorityDate | 2008-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 182.